Maple syrup decreases TDP-43 proteotoxicity in a caenorhabditis elegans model of amyotrophic lateral sclerosis (ALS)

Maple syrup decreases TDP-43 proteotoxicity in a caenorhabditis elegans model of amyotrophic lateral sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease causing death of the motor neurons. Proteotoxicity caused by TDP-43 protein is an important aspect of ALS pathogenesis, with TDP-43 being the main constituent of the aggregates found in patients. We have previously tested the effect...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Aaron, C, Beaudry, G, Parker, J, Therrien, M
Fformat:	Journal article
Cyhoeddwyd:	American Chemical Society 2016

Eitemau Tebyg

TDP-43 based biomarker development in amyotrophic lateral sclerosis
gan: Feneberg, E
Cyhoeddwyd: (2019)

Investigating mechanisms of TDP-43 toxicity in cellular models of amyotrophic lateral sclerosis
gan: Carroll, E
Cyhoeddwyd: (2022)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
gan: Turner, B, et al.
Cyhoeddwyd: (2008)

In vitro transgenic models to elucidate the molecular mechanisms of TDP-43 pathology in amyotrophic lateral sclerosis
gan: Mutihac, R
Cyhoeddwyd: (2013)

Mice with endogenous TDP‐43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis
gan: Wang, Eric T, et al.
Cyhoeddwyd: (2018)

The pathophysiological role of TDP-43 in amyotrophic lateral sclerosis due to C9orf72 mutations
gan: Scaber, J
Cyhoeddwyd: (2017)

What is the role of TDP-43 in C9orf72-related amyotrophic lateral sclerosis and frontemporal dementia?
gan: Scaber, J, et al.
Cyhoeddwyd: (2016)

Amyotrophic lateral sclerosis.
gan: Kiernan, M, et al.
Cyhoeddwyd: (2011)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
gan: Jones, A, et al.
Cyhoeddwyd: (2014)

Biomarkers in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2009)

Neuroimaging in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2012)

The reunification of amyotrophic lateral sclerosis
gan: Turner, M
Cyhoeddwyd: (2018)

The genetics of amyotrophic lateral sclerosis
gan: Schymick, J
Cyhoeddwyd: (2009)

Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology
gan: Feneberg, E, et al.
Cyhoeddwyd: (2020)

Detection and quantification of novel C-terminal TDP-43 fragments in ALS-TDP
gan: Feneberg, E, et al.
Cyhoeddwyd: (2021)

Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction
gan: Gordon, D, et al.
Cyhoeddwyd: (2018)

Retromer dysfunction in amyotrophic lateral sclerosis
gan: Fraenkel, Ernest
Cyhoeddwyd: (2023)

Controversies and priorities in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2013)

Untangling neuroinflammation in amyotrophic lateral sclerosis
gan: Thompson, AG, et al.
Cyhoeddwyd: (2019)

Genetics of sporadic amyotrophic lateral sclerosis.
gan: Schymick, J, et al.
Cyhoeddwyd: (2007)

Neuroimaging endpoints in amyotrophic lateral sclerosis
gan: Menke, R, et al.
Cyhoeddwyd: (2016)

Diagnosis of an intermediate case of maple syrup urine disease: a case report
gan: Lin, Yun-Ting, et al.
Cyhoeddwyd: (2023)

Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.
gan: Hudson, A, et al.
Cyhoeddwyd: (1993)

Sweet food preference in amyotrophic lateral sclerosis
gan: Turner, M, et al.
Cyhoeddwyd: (2017)

Defining pre-symptomatic amyotrophic lateral sclerosis
gan: Benatar, M, et al.
Cyhoeddwyd: (2019)

The tough body at the epicentre of amyotrophic lateral sclerosis
gan: Turner, M, et al.
Cyhoeddwyd: (2017)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
gan: Evans, M, et al.
Cyhoeddwyd: (2013)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis
gan: Evans, M, et al.
Cyhoeddwyd: (2013)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
gan: Abdel-Khalik, J, et al.
Cyhoeddwyd: (2016)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
gan: Fabes, J, et al.
Cyhoeddwyd: (2017)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
gan: Bowser, R, et al.
Cyhoeddwyd: (2011)

Quantifying disease progression in amyotrophic lateral sclerosis.
gan: Simon, N, et al.
Cyhoeddwyd: (2014)

CSF chitinase proteins in amyotrophic lateral sclerosis
gan: Thompson, A, et al.
Cyhoeddwyd: (2019)

Myelin imaging in amyotrophic and primary lateral sclerosis.
gan: Kolind, S, et al.
Cyhoeddwyd: (2013)

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2013)

Imaging cerebral activity in amyotrophic lateral sclerosis
gan: Proudfoot, M, et al.
Cyhoeddwyd: (2019)

Motor system biomarkers in amyotrophic lateral sclerosis
gan: Edmond, EC, et al.
Cyhoeddwyd: (2019)

Advances in the application of MRI to amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2010)

Psychiatric disorders prior to amyotrophic lateral sclerosis
gan: Turner, M, et al.
Cyhoeddwyd: (2016)

Medical significance of Caenorhabditis elegans.
gan: Aboobaker, A, et al.
Cyhoeddwyd: (2000)